Which enzyme activity is most significantly impaired in pyruvate dehydrogenase complex (PDHC) deficiency compared to citrate synthase deficiency?

Explanation

## Distinguishing PDHC Deficiency from Citrate Synthase Deficiency ### Enzymatic Lesion Comparison | Feature | PDHC Deficiency | Citrate Synthase Deficiency | |---------|-----------------|-----------------------------| | **Blocked Step** | Pyruvate → Acetyl-CoA | Acetyl-CoA + OAA → Citrate | | **Location** | Entry to TCA cycle | First committed step of TCA | | **Substrate Accumulation** | Pyruvate, lactate ↑↑ | Acetyl-CoA ↑ | | **TCA Cycle Status** | Cannot enter | Enters but cannot proceed | | **Metabolic Consequence** | Anaerobic metabolism dominance | Impaired oxidative capacity | ### Key Point: **PDHC deficiency prevents pyruvate entry into the TCA cycle entirely**, whereas citrate synthase deficiency allows pyruvate to be converted to acetyl-CoA but blocks the first committed step of the cycle itself. ### High-Yield: PDHC is the **gatekeeper** enzyme linking glycolysis to the TCA cycle. Its deficiency causes: - Severe lactic acidosis (pyruvate → lactate) - Neurological symptoms (brain relies heavily on aerobic metabolism) - Cannot be bypassed by alternative TCA intermediates ### Clinical Pearl: PDHC deficiency presents with **developmental delay, seizures, and lactic acidosis**, often triggered by carbohydrate loading. Citrate synthase deficiency is rarer but presents with progressive myopathy and exercise intolerance. ### Mnemonic: **PDHC = Prior to entry** (blocks entry to TCA); **Citrate synthase = Commits to cycle** (blocks commitment within cycle).